T cells play a critical role in anti-tumor efficacy, and we found that the proportion of CD3+ and CD4+ T cells was slightly increased in the OVA&si-Irg1-LNP group compared to that in the OVA-LNP group (Figure 6J-K). The gene discussed is CD4; the disease is neoplasm.